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Aim Mechanical circulatory support is an alternative strategy as a bridge to
transplantation for critical situations such as circulatory shock or graft
shortage. The purpose of this study was to evaluate long-term results and out-
come after heart transplantation performed in patients with ventricular assis-
tance device (VAD) versus no mechanical circulatory support.
Methods All the patients who underwent heart transplantation between
2005 and 2012 were included in this monocentric retrospective study. We
compared 52 VAD patients who underwent heart transplantation to
289 patients transplanted without VAD.
Results Mean age was 46±11 years in the VAD group vs 51±13 years in
the standard group (p=0.01) and 17% of the VAD patients were women vs
25% (p=0.21). Ischemic time was longer in the VAD group (207±54 vs
169±60 min, p<0.01). There was no difference of primary graft failure (33%
vs 25%, p=0.22) and 1-year mortality (17% vs 28%, p=0.12). Independent risk
factors for 1-year mortality were preoperative VAD (OR 0.40 [0.17-0.97],
p=0.04), recipient age>60 years (OR 0.2.35 [1.34-4.14], p<0.01), recipient
creatinine (OR 1.005 [1.001-1.010], p=0.02), BSA mismatch (OR 4.85 [1.34-
17.54], p=0.02) and ischemic time (OR 1.005 [1.001-1.010], p=0.02). Five-
year survival was 66% in VAD group vs 60% in standard group (p=0.72).
Independent risk factors for 5-years survival recipient age>60 years (HR 1.570
[1.05-2.34], p=0.02), recipient creatinin (HR 1.005 [1.002-1.008], p=0.02),
and ischemic time (HR 1.004 [1.001-1.007], p=0.01).
Conclusion: Bridge to transplantation by ventricular assistance device
reduced one-year mortality and improved mid-term survival rate after heart
transplantation.
The author hereby declares no conflict of interest
0330
Impact of extra-corporeal membrane oxygenation in high-urgency
cardiac transplantation
Cosimo D’Alessandro*, Shaida Varnous, Patrick Farahmand, Mojgan
Laali, Guillaume Lebreton, Pascal Leprince
APHP-GH Pitié-Salpêtrière, Paris, France
*Corresponding author: cosimodalessandro@wanadoo.fr (Cosimo D’Ales-
sandro)
Objectives We evaluated the use of extra-corporeal membrane oxygenation
(ECMO) support as a direct bridge for heart transplantation in high-urgency
(SuperUrgence 1) adult recipients.
Methods Between January 2005 and December 2012, 81 patients sup-
ported with ECMO underwent high-urgency cardiac transplantation at our
Institution (group SU1 ECMO). They were compared to 131 cardiac recipi-
ents who high-urgency transplantation during the same period (group SU1
NoECMO).
Results Forty-four patients were supported with a peripheral ECMO, while
37 patients were supported with a central ECMO. Mean duration of support
before transplantation was 17±12 days. The following characteristics were sig-
nificantly different between group SU1 NoECMO and group SU1 ECMO:
among the recipients, age, 49 years vs. 44 years, p<0.01; age older than 50
years, 61% vs. 42%, p<0.01; waiting time >15 days, 45% vs. 16%, p<0.01;
ischemic etiology, 24% vs. 40%, p=0.02; prior sternotomy, 14% vs. 59%,
p<0.01; preoperative Implantable Cardioverter Defibrillator (ICD), 50% vs.
16%, p<0.01; preoperative ventilation, 6% vs. 41%, p<0.01; preoperative ino-
tropes, 84% vs. 67%, p<0.01, glomerular filtration rate (GFR) 76 vs. 108,
p<0.01. Donor characteristics were similar in both groups. The occurrence of
primary graft dysfunction and one-year mortality in group SU1 NoECMO and
group SU1 ECMO were 18% vs. 42%, p<0.01 and 23% vs. 28%, p=0.37.
Five-year survival was 72% (group SU1 NoECMO) and 66% (SU1 ECMO),
p=0.45. A period analysis of SU1 ECMO patients is resumed in Table 1.
Conclusion In our experience, ECMO support is a reliable option for direct
bridge to heart transplantation and it resulted in satisfactory outcomes as other
high-urgency transplanted patients. 
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Background Operative risk of tricuspid regurgitation (TR) surgery is cur-
rently based on right ventricular (RV) systolic function assessment while bio-
logical markers of RV congestion are under used. The aim of the study was to
assess the additive value of biological markers of RV congestion in predicting
postoperative mortality after TR surgery.
Methods Thirty-seven patients (age 69±13 years) referred for surgical cor-
rection of isolated severe TR (n=13) or TR associated with a left-side heart
valve disease were included. RV congestion was assessed preoperatively using
natremia, uremia, creatinin and bilirubin. RV systolic function was assessed
by echocardiography using tricuspid annular plane systolic excursion
(TAPSE) and RV fractional area change (RVFAC). Outcome was defined as
early postoperative mortality (<30 days).
Results Before surgery, 70% (n=26) patients had moderate to severe TR,
30% (n=11) had RV dysfunction (TAPSE<15mm), and 20% (n=7) both. Bili-
rubin level correlated with TAPSE (r=0.43, P=0.04) and inferior vena cava
diameter (r=–0.46, P=0.01) but not with TR severity. After cardiac surgery,
one patient had persistent moderate to severe TR and 7 patients died. Pre-
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Abstract 0330 – Table: Period Analysis of SU1 ECMO Patients
Era I (2005-2008) Era II (2009-2012) P
RECIPIENT
Etiology DCM 27% 53% 0,02
Central ECMO 66% 25% <0,01
Prior Sternotomy 78% 40% <0,01
Preoperative Ventilation 56% 25% <0.01
GFR 92 124 0,03
DONOR
Age >50 44% 23% 0,04
RESULTS
Primary Graft Failure 32% 53% 0,06
1-Year Mortality 27% 30% 0,75
